Immunological therapy: A novel thriving area for triple-negative breast cancer treatment

X Wang, Y Qi, X Kong, J Zhai, Y Li, Y Song, J Wang… - Cancer letters, 2019 - Elsevier
Triple-negative breast cancer (TNBC) refers to cancers that are low in expression of the
estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor …
被引用次数：47 相关文章

Immunological therapy: A novel thriving area for triple-negative breast cancer treatment.

X Wang, Y Qi, X Kong, J Zhai, Y Li, Y Song, J Wang… - Cancer Letters, 2018 - europepmc.org
Triple-negative breast cancer (TNBC) refers to cancers that are low in expression of the
estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor …
[PDF] google.com

[PDF][PDF] Immunological therapy: A novel thriving area for triple-negative breast cancer treatment

X Wang, Y Qi, X Kong, J Zhai, Y Li, Y Song… - Cancer …, 2019 - drive.google.com
Triple-negative breast cancer (TNBC) refers to cancers that are low in expression of the
estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor …

Immunological therapy: A novel thriving area for triple-negative breast cancer treatment

X Wang, Y Qi, X Kong, J Zhai, Y Li, Y Song… - Cancer …, 2019 - pubmed.ncbi.nlm.nih.gov
Triple-negative breast cancer (TNBC) refers to cancers that are low in expression of the
estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor …